BigCommerce to Announce First Quarter 2024 Financial Results on May 9, 2024
AUSTIN, Texas, April 10, 2024 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading Open SaaS ecommerce platform […]
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology […]
Artesian Water Company Prepared to Fully Comply with EPA’s New PFAS Drinking Water Standard
NEWARK, Del., April 10, 2024 (GLOBE NEWSWIRE) — Artesian Water Company, Inc. (Artesian), a subsidiary of Artesian Resources Corporation (Nasdaq: […]
Laureate Education Announces Date of First Quarter 2024 Earnings Release and Conference Call
MIAMI, April 10, 2024 (GLOBE NEWSWIRE) — Laureate Education, Inc. (NASDAQ: LAUR) plans to release results for the quarter ended […]
Costco Wholesale Corporation Reports March Sales Results and Announces an Increase in Its Quarterly Cash Dividend
ISSAQUAH, Wash., April 10, 2024 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net […]
Plexus Sets Fiscal Second Quarter 2024 Earnings Release Date
NEENAH, WI, April 10, 2024 (GLOBE NEWSWIRE) — Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal second […]
Latham Group, Inc. Announces First Quarter 2024 Earnings Release and Conference Call Date
LATHAM, N.Y., April 10, 2024 (GLOBE NEWSWIRE) — Latham Group, Inc. (“Latham” or “the Company”), the largest designer, manufacturer, and […]
Richardson Electronics Reports Third Quarter Fiscal 2024 Results and Declares Quarterly Cash Dividend
Sales increased 18.7% sequentially, reflecting improving business conditions. Inventory decreased $4.0 million sequentially, reflecting focus on improving working capital levels. […]
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrolling End-of-Phase […]
Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
ZUG, Switzerland, April 10, 2024 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 […]
